Outcome of peritonitis treated with intraperitoneal (IP) weekly vancomycin and IP daily netilmicin

Journal of Nephrology

Volumn 12, Issue 5, 1999, Pages 318-321

  Chadwick, Denise H ^a   Agarwal, Sanjay ^a   Vora, Bhavesh J ^a   Hair, Margaret ^a   McKewan, Anne ^a   Gokal, Ram ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Cefazolin; Methicillin resistant staphylococcal aureus (MRSA); Methicillin resistant staphylococcal epidermidis (MRSE); Peritonitis; Vancomycin; Vancomycin resistant enterococci (VRE)

Indexed keywords

NETILMICIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL PERITONITIS; DRUG EFFICACY; ENTEROCOCCUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; STAPHYLOCOCCUS; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GENTAMICINS; HUMANS; MALE; MIDDLE AGED; NETILMICIN; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; TREATMENT OUTCOME; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 0033395589     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bernardini J, Holley JL, Johnston JR, et al. An analysis of ten years trend in infection in adults on continuous ambulatory peritoneal dialysis. Clin Nephrol 1991; 36: 29-34.
2. Report of the working party BSAC. Diagnosis and management of peritonitis in CAPD. Lancet, 1987; 1: 845-9.
3. Zimmerman SW, O'Brien M, Wiedenhoeft FA et al. Staphylococcus aureus peritoneal catheter related infection: A cause of catheter loss and peritonitis. Perit Dial Int 1988; 8: 191-4.
4. Keller E. Pharmacokinetics and pharmacodynamics of antistaphylococcal antibiotics in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1993; 13(suppl 2): S367-70.
5. Keane WF, Everett ED, Golper TA, Gokal R, Halstenson C, Kawaguchi Y, et al. Peritoneal dialysis related peritonitis treatment recommendations: 1993 update. The Ad Hoc advisory committee on peritonitis management. Perit Dial Int 1993; 13: 14-28.
6. Keane WF, Alexander SR, Bailie GR, Boeschoten E, Gokal R, Golper TA, et al. Peritoneal dialysis related peritonitis treatment recommendations. Perit Dial Int 1996; 16: 557-73.
7. Gokal R, RamosJM, Francis DNA, Warn MK, Kerr DNS. Peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1982; 1: 1388-91.
8. Gruer LA, Turney JH, Curley, et al. Vancomycin and tobramicin in the treatment of continuous ambulatory dialysis peritonitis. Nephron 1985; 41: 279-82.
9. Were AJ, Marsden A, Tooth A, Ramsden R, Mistry CD, Gokal R. Netilmicin and vancomycin in the treatment of peritonitis in continuous ambulatory peritoneal dialysis. Clin Nephrol 1992; 37: 209-13.
10. Brauner L, Kahlmeter G, Lindholm T, Simonsen O. Vancomycin and netilmicin as first line treatment of peritonitis in continuous ambulatory peritoneal dialysis patients. J Antimicrob Chcmother 1985; 15 (6): 751-8.
11. Lye WC, Wong PL, Van der Straaten JC, Leong SO, Lee EJ. A prospective and randomised comparison of single versus multidose gcntamicin in the treatment of continuous ambulatory peritoneal dialysis peritonitis. Adv Perit Dial 1995; 11: 79-81.
12. Bistrup C, Siboni AH, Pederson RS. Peritonitis among patients treated with continuous ambulatory peritoneal dialysis. Ugesker Laeger (Denmark) 1995; 157 (28): 4023-6.
13. Golper TA, Tranaeus A. Vancomycin revisted. Perit Dial Int 1996; 16: 116-7.
14. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1995; 44(No RR-12): 557-73.
15. Vas S, Bargman J, Oreopoulos DG. Treatment in PD patients of peritonitis caused by Gram-positive organisms with a single daily dose of antibiotics. Perit Dial Int 1997; 17: 91-4.
16. Lai MN, Kao MT, Chen CC, Cheung SY, Chung WK. Intraperitoneal once-daily dose of cefazolin and gentamicin for treating CAPD peritonitis. Perit Dial Int 1996; 17: 91-4.
17. Sandoe J, Gokal R, Struthers K. Vancomycin-resistant enterococci and empirical vancomycin for CAPD peritonitis. Perit Dial Int 1997; 17: 617-8.
18. Low CL, Eisele G, Cerda J, Venezia R, Haaley E, Weathervax D, Bailie GR. Low prevalence of vancomycin-resistant enterococci in dialysis outpatients with a history of vancomycin use. Perit Dial Int 1996; 16: 651-2